Publication | Closed Access

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Placebo-controlled Phase 3Pleural DiseaseAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyChemotherapy-naive PatientsRadiologyHealth Sciences